drugset / Trial / NCT06406205
A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to assess the efficacy of QL1074 compared with placebo in achieving renal response after 52 weeks of therapy in subjects with Active Lupus Nephritis.
Timeline
- Start
- 2023-12-25
- Primary completion
- 2027-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Voclosporin | Other / unclassified | 23.7 mg | Oral |